The Potentials of Ergothioneine in the management of diseases in animals
Downloads
The amino acid histidine is the source of the special nutraceutical ergothioneine (ERG), which is a potent antioxidant. Higher plants and animals, who obtain it from the soil and their food, respectively, do not synthesize it; instead, they obtain it through particular microorganisms, such as actinobacteria and mushrooms. Solute carrier family 22, member 4 (SLC22A4), sometimes referred to as organic cation transporter novel type-1 is an incredibly selective transporter for the substance that is only present in animals (OCTN-1). Depending on how OCTN 1 is expressed in different tissues, particularly in those that are more susceptible to oxidative stress, such as erythrocytes, the buildup of ERG differs. ERG concentration is decreased in a number of chronic inflammatory illnesses, and it appears to have potent cytoprotective actions.It has been certified to be relatively safe by regulatory authorities compared to many other antioxidants.
Akanmu, D., Cecchini, R., Aruoma, O.I. and Halliwell, B. (1991). The antioxidant action of ergothioneine. Archives of Biochemistry and Biophysics, 288: 10–16.
Aruoma, O. I., Spencer, J. P., and Mahmood, N. (1999). Protection against oxidative damage and cell death by the natural antioxidant ergothioneine. Food and Chemical Toxicology: 37(11), 1043–1053.
Asahi, T., Wu, X., Shimoda, H., Hisaka,S., Harada, E., Kanno, T., Nakamura, Y., Kato, Y. and Osawa, T. (2016). A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation. Journal of Bioscience, Biotechnology and Biochemistry, 80(2): 313-317.
Bedirli, A., Sakrak, O., Muhtaroglu, S., Soyuer, I., Guler, I., Riza, A. and Erdogan, E. M. (2004) Ergothioneine pretreatment protects the liver from ischaemia–reperfusion injury caused by increasing hepatic heat-shock-protein 70. Journal of Surgical Research, 122: 96–102.
Bull, M.J. and N.T. Plummer, Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas), 2014. 13(6): p. 17-22.
Cheah, I. K. and Halliwell, B. (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochimica et Biophysica Acta, 1822: 784–793.
Cheah, I. K., and Halliwell, B. (2021). Ergothioneine, recent developments. Redox biology, 42, 101868. https://doi.org/10.1016/j.redox.2021.101868
Cheah, I. K., Tang, R., Ye, P., Yew, T. S. Z., Lim, K. H. S. and Halliwell, B. (2016). Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence? Free Radical Research, 50(1): 14-25.
Cheah, I.K., Tang, R. M.Y., Yew, T.S.Z.. Lim, H.H.C and Halliwell, B. (2017). Administration of pure ergothioneine to healthy human subjects: uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxidants and Redox Signaling, 26(5): 193-206.
Clerkin, C.G., M. Matzinger, M.A. Selo, B.N. Talbot, J.J. Walsh, and C. Ehrhardt, Aromatic Substitution Reaction of Ergothioneine - a Novel Mechanism of Xenobiotic Deactivation. The FASEB Journal, 2017. 31(S1): p. 821.1-821.1.
Cumming, B.M., Chinta, K.C. Reddy, V.P. and Steyn A.J.C. (2018) Role of Ergothioneine in Microbial Physiology and Pathogenesis. Antioxidants and redox signaling. 28(6): p. 431- 444.
Day, B.J. (2008) Antioxidants as potential therapeutics for lung fibrosis. Antioxid. Redox Signal., 10, 355–370.
European Food Safety Authority (2017) Panel on Dietetic Products, Nutrition and Allergies (NDA); Turck, D.; Bresson, J.-L.; Burlingame, B.; Dean, T.; Fairweather-Tait, S.; Heinonen, M.; Hirsch-Ernst, K.I.; Mangelsdorf, I.; McArdle, H.J.; et al. Statement on the safety of synthetic l-ergothioneine as a novel food”Supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women. EFSA J. 2017, 15
Encarnacion, A.B., F. Fagutao, I. Hirono, H. Ushio, and T. Ohshima, Effects of ergothioneine from mushrooms (Flammulina velutipes) on melanosis and lipid oxidation of kuruma shrimp (Marsupenaeus japonicus). J Agric Food Chem, 2010. 58(4): p. 2577-85.
Ey, J., Schomig, E. and Taubert, D. (2007). Dietary sources and antioxidant effects of ergothioneine. Journal of Agriculture and Food Chemistry, 55: 6466–6474.
Feng, F.; Zhang, J.; Wang, Z.; Wu, Q.; Zhou, X. Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis. Exp. Ther. Med. 2019, 18, 802–816.
Feng, J., Che, Y.S., Milse, J., Yin, Y.J., Liu. L., Ruckert, C., Shen, X.H., Qi, S.W., Kalinowski, J. and Liu, S.J. (2006). The gene ncgl2918 encodes a novel maleylpyruvate isomerase that needs mycothiol as cofactor and links mycothiol biosynthesis and gentisate assimilation in Corynebacterium glutamicum. J Biol Chem, 281: 10778-10785.
Forster, R., Spezia, F., Papineau, D., Sabadie, C., Erdelmeier, I., Moutet, M. and Yadan, J. C. (2015). Reproductive safety evaluation of L-Ergothioneine. Food and Chemical Toxicology, 80: 85-91.
Franzoni, F., Colognato, R, Galetta, F, Laurenza, I., Barsotti,, D.,. Stefano, R,., Bocchetti, R., Regol, F., Carpi, A. and Balbarini, H. (2006). An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox . Biomedicine Pharmacotherapy, 60: 453-457.
Fu T-T and Shen L (2022) Ergothioneine as a Natural Antioxidant Against Oxidative StressRelated Diseases. Front. Pharmacol. 13:850813. doi: 10.3389/fphar.2022.850813
Graham, S.F.; Chevallier, O.P.; Kumar, P.; Türkoglu, O.; Bahado-Singh, R. Metabolomic profiling of brain ˇ from infants who died from sudden infant death syndrome reveals novel predictive biomarkers. J. Perinatol. 2016, 37, 91–97.
Grigat, S. Harlfinger, S. Pal, S. Striebinger, R. Golz, S Geerts, A. Lazar, A Schomig, E Grundemann, D. (2007). Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations, Biochem. Pharmacol. 74:309–316.
Grundemann, D Harlfinger, S. Golz, S Geerts, A. Lazar, A Berkels, R. Jung, N. Rubbert, A. Schomig, E. (2005) Discovery of the ergothioneine transporter, Proc. Natl. Acad. Sci. USA. 102 5256–5261.
Halliwell, B. and Gutteridge, J.M. (2007). .Free Radicals in Biology and Medicine, Fourth Ed..Clarendon Press, Oxford, UK.
Halliwell, B. and Lee, C.Y. (2010). Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxidant and Redox Signalling, 13: 145–156.
Halliwell, B.; Cheah, I.K.; Tang, R.M.Y. Ergothioneine”A diet-derived antioxidant with therapeutic potential. FEBS Lett. 2018, 592, 3357–3366
Hartman, P. E. (1990) Ergothioneine as antioxidant, Methods Enzymol. 186 310–318
Hseu, Y. C., Lo, H. W., Korivi, M., Tsai, Y. C., Tang, M. J. and Yang, H. L. (2015). Dermato-protective properties of ergothioneine through induction of Nrf2/ARE-mediated antioxidant genes in UVA-irradiated Human keratinocytes. Free Radical Biology and Medicine, 86: 102-107.
Kalaras, M.D.; Richie, J.P. Calcagnotto, A.; Beelman, R.B. (2017) Mushrooms: A rich source of the antioxidants ergothioneine and glutathione. Food Chem., 233, 429–433.
Kaneko, I., Takeuchi, Y., Yamaoka, Y., Tanaka, Y., Fukuda, T., Fukumori, Y., Mayumi, T. and Hama, T. (1980). Quantitative determination of ergothioneine in plasma and tissues by TLC-densitometry, Chemical and Pharmaceutical Bulletin (Tokyo), 28: 3093–3097.
Kei, O., Kouji, K., Yuri, O, Hitoshi, M. and Daniel, B.Y. (2005). L-Ergothioneine scavenges superoxide and singlet oxygen and suppresses TNF- and IVIIVIP expression in UV-irradiated human dermal fibroblasts. Journal of Cosmetics Science, 56: 17-27.
Khonde, P.L. and Jardine, A. (2015). Improved synthesis of the super antioxidant, ergothioneine, and its biosynthetic pathway intermediates. Organic and Biomolecular Chemistry, 13: 1415-1419.
Kobayashi, D., Aizawa, S., Maeda, T., Tsuboi, I., Yabuuchi, H., Nezu, J., Tsuji, A., and Tamai, I. (2004). Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation. Experimental hematology, 32(12), 1156–1162.
Lamhonwah, A.M. Tein, I (2006) Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria, Biochem. Biophys. Res. Commun. 345 (2006) 1315–1325.
Lamhonwah, A.M.; Hawkins, C.E.; Tam, C.; Wong, J.; Mai, L.; Tein, I. Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain Dev. 2008, 30, 31–42
Li, R. W. S., Yang, C., Sit, A.S.M., Kwan, Y.W., Lee, S. M. Y., Hoi, M. P. M., Chan, S. W., Hausman, M., Vanhoutte, P. M. and Leung, G. P. H. (2014). Uptake and protective effects of ergothioneine in human endothelial cells. The Journal of Pharmacology and Experimental Therapeutics, 350: 691–700.
Libby, P., Ridker, P. M. and Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis, Nature, 473: 317–325.
Marone, P.A., Trampota, J. and Weisman, S. (2016). A safety evaluation of a nature-identical L-ergothioneine in Sprague-Dawley rats. International Journal of Toxicology, 35(5): 568-583
Martin, K.R. (2010). The bioactive agent ergothioneine, a key component of dietary mushrooms, inhibits monocyte binding to endothelial cells characteristic of early cardiovascular disease, Journal of Medicine and Food, 13: 1340–1346.
Mitsuyama, H. and May, J.M. (1999). Uptake and antioxidant effects of ergothioneine in human erythrocytes. Clinical Science, 97(4): 407-411.
Moncaster, J.; Walsh, D.T.; Gentleman, S.M.; Jen, L.-S.; Aruoma, O.I. Ergothioneine treatment protects neurons against N-methyl-D-aspartate excitotoxicity in an in vivo rat retinal model. Neurosci. Lett. 2002, 328, 55–5
Muramatsu, H., Matsuo, H., Okada, N., Ueda, M., Yamamoto, H. and Kato, S. I. (2013). Characterization of ergothionase from Burkholderia specie HME13 and its application to enzymatic quantification of ergothioneine. Applied Microbiology and Biotechnology, 97: 5389–5400
Nakamichi, N. Nakayama, K., Ishimoto, T., Masuo, Y., Wakayama, T., Sekiguchi, H., Satoh, K., Usumi, K., Iseki, S. and Kat, Y. (2016). Food-derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice. Brain and Behaviour, 6(6): 477-484.
Nakamura, T Sugiura,S Kobayashi, D Yoshida, K Yabuuchi, H. Aizawa, S Maeda, T Tamai, (2007) Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene, Pharm. Res. 24 1628–1635.
Nauta, R. J., Tsimoyiannis, E., Uribe, M., Walsh, D. and Miller, A. (1990). Butterfield, oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surgery Gynecology and Obstetrics, 171: 120–125.
Paul, B.D. and Snyder, S.H. (2009). The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death and Differentiation, 17: 1-7.
Peltekova, V. D., Wintle, R. F., Rubin, L. A., Amos, C. I., Huang, Q., Gu, X., Newman, B., Van, B., Oene, M., Cescon, D., Greenberg, G., Griffiths, A. M. and St George-Hyslop, P. H. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genetics, 36(5): 471-5
Pike, C.J., Walencewicz, A.J., Glabe, C. G. and Cotman, C.W. (1991). In vitro aeging of beta amyloid protein causes peptide aggregation and neurotoxicity. Brain Research, 563: 311–314.
Pluskal, T, Ueno, M. and Yanagida, M. (2014). Genetic and metabolic dissection of the ergothioneine and selenoneine biosynthetic pathway in the fission yeast, Sacromycetes pombe and construction of an over production system. PLoS ONE, 9:e97774. doi:10.1371/journal.pone.0179360
Pochini, L., Scalise, M., and Indiveri, C. (2015). Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function. International immunopharmacology, 29(1), 21–26. https://doi.org/10.1016/j.intimp.2015.04.040
Ramirez-Martinez, A., Wesolek, N., Yadan, J.C., Moutet, M. and Roudot, A. C. (2016).Intake assessment of L-ergothioneine in some European countries and in the United States. Journal of Human and Ecological Risk Assessment, 22(3): 12-18.
SaoEmani, C., Williams, M.J., Wiid, I.J., Hiten, N.F., Viljoen, A.J. and Pietersen, R.D.D. (2013). Ergothioneine is a secreted antioxidant in Mycobacterium semegmatis. Antimicrobial Agents and Chemotherapy, 57: 3202–3207.
Schauss, A.G.; Béres, E.; Vértesi, A.; Frank, Z.; Pasics, I.; Endres, J.; Aruoma, O.I.; Hirka, G. The Effect of Ergothioneine on Clastogenic Potential and Mutagenic Activity. Int. J. Toxicol. 2011, 30, 405–409
Schauss, A.G.; Béres, E.; Vértesi, A.; Frank, Z.; Pasics, I.; Endres, J.; Aruoma, O.I.; Hirka, G. The Effect of Ergothioneine on Clastogenic Potential and Mutagenic Activity. Int. J. Toxicol. 2011, 30, 405–409
Schauss, A.G.; Vértesi, A.; Endres, J.R.; Hirka, G.; Clewell, A.E.; Qureshi, I.; Pasics, I. (2010). Evaluation of the safety of the dietary antioxidant ergothioneine using the bacterial reverse mutation assay. Toxicology, 278: 39–45.
Seet, R.C., Lee, C.Y., Loke, W.M., Huang, S.H., Huang, H., Looi, W.F., Chew, E.S., Quek, A.M., Lim, E.C. and Halliwell, B. (2011). Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? Free Radical Biology and Medicine, 50: 1787–1793.
Sheridan, K.J., B.E. Lechner, G.O. Keeffe, M.A. Keller, E.R. Werner, H. Lindner, G.W. Jones, H. Haas, and S. Doyle, Ergothioneine Biosynthesis and Functionality in the Opportunistic Fungal Pathogen, Aspergillus fumigatus. Sci Rep, 2016. 6: p. 35306.
Smith, E., Ottosson, F., Hellstrand, S., Ericson, U., Orho-Melander, M., Fernandez, C., and Melander, O. (2020). Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart (British Cardiac Society), 106(9), 691–697. https://doi.org/10.1136/heartjnl-2019-315485
Song, H, Hu, W., Naowarojna, N., Her, A. S., Wang, S., Desai, R., Qin, L., Chen, X. and Liu, P. (2015). Maechanistic studies of a novel C-S lyase in ergothioneine biosynthesis: the involvement of a sulpenic acid intermediate. Scientific Reports 5: 118-126.
Song, T.-Y.; Lin, H.-C.; Chen, C.-L.; Wu, J.-H.; Liao, J.-W.; Hu, M.-L. Ergothioneine and melatonin attenuate oxidative stress and protect against learning and memory deficits in C57BL/6J mice treated with D-galactose. Free Radic. Res. 2014, 48, 1049–1060. [CrossRef]
Sotgia, S., Pisanu, E, Pintus, G., Erre, G. L. and Pinna, G. A. (2013). Plasma l-ergothioneine measurement by high-performance liquid chromatography and capillary electrophoresis after pre-column derivatization with 5-iodoacetamidofluorescein (5-iaf) and fluorescence detection. PLoS ONE, 8(7): e70374. doi:10.1371/journal.pone.01693623
Sotgia, S., Zinellu, A., Arru, D., Nieddu, S., Strina, A., Ariu, F., Pintus, G., Carru, C., Bogliolo, L. and Ledda, S. (2015). Amniotic fluid l-ergothioneine concentrations in pregnant sheep after natural mating and transfer of vitrified/thawed in vitro produced embryos. Research in Veterinary Science, 102: 238-241.
Tamai, H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, A. Tsuji, O. (1997). Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN 1. FEBS Letters, 419: 107–111.
Tang, R.M., Cheah, I.K., Yew, T.S. and Halliwell, B. (2018). Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues. Scientific Reports, 8: 1601-1615.
Tang, R.M.Y.; Cheah, I.K.-M.; Yew, T.S.K.; Halliwell, B. (2018) Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues. Sci. Rep., 8, 1601.
Taubert, D., Lazar, A., Grimberg, G., Jung, N., Rubbert, A., Delank, K. S., Perniok, A., Erdmann, E. and Schomig, E. (2006) Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study. Journal of Rheumatology, 33: 2139–2145.
Turck, D.; Bresson, J.L.; Burlingame, B.; Dean, T.; Fairweather-Tait, S.; Heinonen, M.; Hirsch-Ernst, K.I.; Mangelsdorf, I.; McArdle, H.J.; Naska, A.; et al. Safety of synthetic l-ergothioneine (Ergoneine®) as a novel food pursuant to Regulation (EC) No 258/97. EFSA J. 2016, 14, e04629.
Vickers, T.J. and Fairlamb, A.H. (2004). Trypanothione S-transferase activity in a trypanosomatid ribosomal elongation factor 1B. Journal of Biological Chemistry, 279: 27246–27256.
Wang LZ, Thuya WL, Toh DS, Lie MG, Lau JY, Kong LR, Wan SC, Chua KN, Lee EJ, Goh BC (2013). Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometry. J Mass Spectrom. Mar;48(3) 406-412. doi:10.1002/jms.3150. PMID: 23494799.
Yang, N. C., Lin, H. C., Wu, J. H., Ou, H. C., Chai, Y. C., Tseng, C. Y., Liao, J. W. and Song, T. Y. (2012). Ergothioneine protects against neuronal injury induced by β-amyloid in mice. Food and Chemical Toxicology, 50(11): 3902-3911.
Yoshida, S, Shime, H., Funami, K., Takaki, H., Matsumoto, M. and Kasahara, M. (2017). The Antioxidant ergothioneine augments the immunomodulatory function of TLR agonists by direct action on macrophages. PLoS ONE, 12(1): e0169360, doi:10.1371/journal.pone.0169360
Zhang, Y., Bond, C. S., Bailey, S., Cunningham, M. L., Fairlamb, A. H. and Hunter, W. N. (1996). The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution. Protein Science, 5(1): 52-61.
Zhu, B. Z., Mao, L., Fan, R. M., Zhu, J. G., Zhang, Y. N., Wang, J., Kalyanaraman, B., and Frei, B. (2011). Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. Chemical research in toxicology, 24(1), 30–34. https://doi.org/10.1021/tx100214t
Copyright (c) 2023 Adakole Adah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Veterinary Medicine Journal by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The Journal allows the author to hold the copyright of the article without restrictions.
2. The Journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
11.jpg)
11.png)
